POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	1aye	PROCARBOXYPEPTIDASE A2 (Homo sapiens)	5 / 12	MET A  93 GLN A  83 VAL A  82 LEU A   4 GLN A 120	None	1.16A	20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	1pcg	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	MET A 343 LEU A 346 LEU A 391 ARG A 394 LEU A 384	EST  A   1 ( 4.0A) EST  A   1 (-4.4A) EST  A   1 ( 3.9A) EST  A   1 (-3.7A) None	1.22A	28.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 745 ARG A 752 LEU A 873	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A)	0.74A	46.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 745 ARG A 752 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A)	1.00A	46.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2gyt	DELETED IN LIVER CANCER 1 PROTEIN, ISOFORM 2 (Homo sapiens)	5 / 12	LEU A  66 ASN A  67 VAL A  74 LEU A  34 LEU A  46	None	1.29A	13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA (Homo sapiens)	5 / 12	LEU B1161 GLY B1192 LEU B1199 MET B1205 LEU B1152	None	1.30A	15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA (Homo sapiens)	5 / 12	LEU B1161 VAL B1358 LEU B1199 MET B1205 LEU B1152	None	1.38A	15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	MET A 343 LEU A 346 LEU A 391 ARG A 394 LEU A 384	EST  A 596 (-4.8A) EST  A 596 (-4.4A) EST  A 596 ( 4.6A) EST  A 596 (-4.0A) None	1.14A	26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2oj4	REGULATOR OF G-PROTEIN SIGNALING 3 (Homo sapiens)	5 / 12	LEU A  22 GLY A  21 LEU A  12 MET A 109 LEU A  29	None	1.28A	20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2wl8	PEROXISOMAL BIOGENESIS FACTOR 19 (Homo sapiens)	5 / 12	LEU A 268 GLY A 270 GLN A 221 MET A 225 LEU A 258	None	1.36A	17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	2y05	PROSTAGLANDIN REDUCTASE 1 (Homo sapiens)	5 / 12	LEU A 322 ASN A 321 GLY A 152 VAL A 154 LEU A 185	None NAP  A 701 (-3.1A) NAP  A 701 (-3.1A) NAP  A 701 (-3.7A) None	1.29A	22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3ehs	FUSION PROTEIN OF CRFR1 EXTRACELLULAR DOMAIN AND MBP (Escherichia coli; Homo sapiens)	5 / 12	LEU A-189 VAL A   8 LEU A-151 MET A-145 LEU A-198	None	1.44A	20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3h68	SERINE/THREONINE-PRO TEIN PHOSPHATASE 5 (Homo sapiens)	5 / 12	LEU A 286 GLY A 288 VAL A 186 MET A 191 LEU A 259	None	1.40A	19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3j9p	MALTOSE-BINDING PERIPLASMIC PROTEIN, TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY A MEMBER 1 CHIMERA (Escherichia coli; Homo sapiens)	5 / 12	LEU D 955 ASN D 954 GLY D 958 VAL D 961 LEU D 870	None	1.36A	11.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	ASN A 719 GLY A 722 GLN A 725 MET A 759 ARG A 766 LEU A 887	WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) WOW  A   1 (-4.0A)	1.21A	49.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	LEU A 718 ASN A 719 GLY A 722 MET A 759 LEU A 763 ARG A 766 MET A 801 LEU A 887	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 (-3.7A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-4.0A)	0.95A	49.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3rip	GAMMA-TUBULIN COMPLEX COMPONENT 4 (Homo sapiens)	5 / 12	LEU A 196 GLY A 194 VAL A 283 GLN A 186 LEU A 187	None	1.33A	18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	3zhp	CALCIUM-BINDING PROTEIN 39-LIKE (Homo sapiens)	5 / 12	MET A 258 LEU A 262 ASN A 260 LEU A 305 LEU A 294	None	1.40A	22.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 563 ASN A 564 GLY A 567 GLN A 570 VAL A 571 MET A 604 ARG A 611	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None None MOF  A 801 (-4.2A)	1.01A	96.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 563 GLY A 567 GLN A 570 VAL A 571 MET A 604 LEU A 608 ARG A 611 MET A 646 LEU A 732	MOF  A 801 (-3.9A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.61A	96.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 769 GLN A 776 LEU A 814 ARG A 817 MET A 852 LEU A 938	CV7  A1987 (-4.1A) CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A)	0.61A	51.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	4wmh	HEME OXYGENASE 2 (Homo sapiens)	5 / 12	MET A 158 LEU A 161 GLY A 164 GLN A 165 VAL A 166	None	1.07A	22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	5iry	DESMOCOLLIN-1 (Homo sapiens)	5 / 12	LEU A   9 LEU A  50 ARG A  64 GLN A  22 LEU A  76	None	1.44A	18.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLN A 776 LEU A 814 ARG A 817 MET A 852	ECV  A1101 (-3.1A) ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A)	1.34A	41.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 LEU A 814 ARG A 817 MET A 852 LEU A 938	ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) ECV  A1101 ( 4.3A)	1.30A	41.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 769 GLN A 776 LEU A 814 ARG A 817 LEU A 938	ECV  A1101 (-4.7A) ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 ( 4.3A)	0.51A	41.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NHZ_A_486A800_1 (GLUCOCORTICOID RECEPTOR)	5xct	VL-SARAH(S37C)CHIMER A (Homo sapiens; Mus musculus)	5 / 12	ASN B  34 GLY B  46 VAL B  58 GLN B   6 LEU B  21	None	1.41A	21.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1NHZ_A_486A800_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	4 / 4	TRP A 600 MET A 601 PHE A 623 TYR A 735	None MOF  A 801 (-3.7A) MOF  A 801 (-4.7A) MOF  A 801 (-4.8A)	1.16A	96.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	1d9n	METHYL-CPG-BINDING PROTEIN MBD1 (Homo sapiens)	5 / 12	LEU A  49 GLY A  14 PHE A  62 LEU A  69 CYH A  57	None	1.30A	16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	1x40	ARAP2 (Homo sapiens)	5 / 12	LEU A  68 LEU A  27 LEU A  52 CYH A  45 VAL A  16	None	1.35A	17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	1xb7	STEROID HORMONE RECEPTOR ERR1 (Homo sapiens)	5 / 12	LEU A 327 TRP A 361 MET A 362 ARG A 372 LEU A 401	None	0.75A	27.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 700 LEU A 707 GLY A 708 GLN A 711 ARG A 752	None BHM  A   1 ( 4.2A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A)	1.38A	53.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 701 LEU A 707 GLY A 708 GLN A 711 MET A 742 MET A 745 ARG A 752	None BHM  A   1 ( 4.2A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A)	0.55A	53.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	2g9n	EUKARYOTIC INITIATION FACTOR 4A-I (Homo sapiens)	5 / 12	LEU A 181 GLN A  93 PHE A 200 LEU A 203 VAL A 120	None None None MLY  A 202 ( 4.2A) None	1.44A	21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	2gpv	ESTROGEN-RELATED RECEPTOR GAMMA (Homo sapiens)	6 / 12	LEU A 265 LEU A 271 TRP A 305 MET A 306 ARG A 316 LEU A 345	None OHT  A 500 ( 4.4A) None OHT  A 500 (-3.9A) OHT  A 500 (-3.8A) OHT  A 500 (-4.3A)	0.74A	28.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	2ppl	PANCREATIC LIPASE-RELATED PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 209 LEU A 172 GLY A  95 TRP A 104 VAL A 105	None	1.39A	18.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	10 / 12	LEU A 715 LEU A 721 GLY A 722 GLN A 725 MET A 756 MET A 759 ARG A 766 PHE A 794 CYH A 891 VAL A 912	WOW  A   1 (-3.9A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) WOW  A   1 (-4.4A) WOW  A   1 (-3.5A) None	0.69A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 715 MET A 756 MET A 759 PHE A 794 LEU A 797 CYH A 891 VAL A 912	WOW  A   1 (-3.9A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-4.4A) WOW  A   1 ( 4.5A) WOW  A   1 (-3.5A) None	0.97A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	LEU A 715 TRP A 755 MET A 756 PHE A 794 CYH A 891	WOW  A   1 (-3.9A) None WOW  A   1 ( 4.1A) WOW  A   1 (-4.4A) WOW  A   1 (-3.5A)	1.05A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4a35	MITOCHONDRIAL ENOLASE SUPERFAMILY MEMBER 1 (Homo sapiens)	5 / 12	LEU A 123 LEU A 129 GLN A 133 PHE A  95 CYH A 153	None	1.06A	20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4a69	HISTONE DEACETYLASE 3, (Homo sapiens)	5 / 12	LEU A 133 GLY A 132 ARG A  28 PHE A 200 VAL A 253	None	1.39A	21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4bkx	HISTONE DEACETYLASE 1 (Homo sapiens)	5 / 12	LEU B 139 GLY B 138 ARG B  34 PHE B 205 VAL B 258	None	1.36A	19.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLY A 568 GLN A 570 TRP A 600 MET A 601 CYH A 736	None MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 (-3.7A)	1.12A	53.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 566 GLY A 567 GLN A 570 TRP A 600 MET A 601 ARG A 611 CYH A 736	MOF  A 801 ( 4.6A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A)	0.48A	53.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 566 GLY A 567 GLN A 570 TRP A 600 MET A 601 MET A 604 ARG A 611	MOF  A 801 ( 4.6A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) None MOF  A 801 (-4.2A)	0.78A	53.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 766 LEU A 772 GLN A 776 TRP A 806 MET A 807 ARG A 817 CYH A 942	CV7  A1987 (-3.6A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) None CV7  A1987 ( 3.9A) CV7  A1987 (-3.7A) CV7  A1987 (-4.0A)	0.50A	52.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 766 TRP A 806 MET A 807 ARG A 817 LEU A 848 CYH A 942	CV7  A1987 (-3.6A) None CV7  A1987 ( 3.9A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.4A) CV7  A1987 (-4.0A)	0.79A	52.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 766 GLN A 776 TRP A 806 MET A 807 ARG A 817 LEU A 848 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) None ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) None ECV  A1101 (-4.0A)	0.95A	40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 766 LEU A 772 GLN A 776 TRP A 806 MET A 807 ARG A 817 CYH A 942	ECV  A1101 ( 3.9A) ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) None ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) ECV  A1101 (-4.0A)	0.61A	40.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_1 (PROGESTERONE RECEPTOR)	5vhi	26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 2 (Homo sapiens)	5 / 12	LEU f 445 LEU f 487 GLY f 486 CYH f 459 VAL f 497	None	1.42A	15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	1pl0	BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH (Homo sapiens)	4 / 7	GLU A 501 LEU A 505 MET A 312 TYR A 464	None	1.03A	18.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	4 / 7	LEU A 704 ASN A 705 GLU A 709 LEU A 712	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) None None	0.53A	53.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	2d5r	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 7 (Homo sapiens)	4 / 7	LEU A 174 GLU A 177 LEU A 179 TYR A 160	None	1.11A	23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	2nlk	PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, G VARIANT (FRAGMENT) (Homo sapiens)	4 / 7	LEU A1089 ASN A1087 LEU A1116 MET A1076	None	1.26A	16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3c5w	PP2A A SUBUNIT (Homo sapiens)	4 / 7	LEU A  29 ASN A  30 GLU A  19 LEU A  16	None	1.13A	26.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3edy	TRIPEPTIDYL-PEPTIDAS E 1 (Homo sapiens)	4 / 7	ASN A 489 GLU A 490 LEU A 494 TYR A  79	None None None EDO  A 704 (-4.6A)	1.22A	19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3iu6	PROTEIN POLYBROMO-1 (Homo sapiens)	4 / 7	LEU A 847 ASN A 850 GLU A 852 LEU A 854	None	1.24A	20.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 7	LEU A 718 ASN A 719 GLU A 723 LEU A 726 MET A 801 TYR A 890	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) None None WOW  A   1 (-4.2A) WOW  A   1 (-3.9A)	0.33A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 7	LEU A 718 ASN A 719 LEU A 726 MET A 801 TYR A 890 MET A 909	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) None WOW  A   1 (-4.2A) WOW  A   1 (-3.9A) None	0.87A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3nuu	PKB-LIKE (Homo sapiens)	4 / 7	LEU A 206 ASN A 210 GLU A 166 LEU A 168	None	1.17A	23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3p0u	NUCLEAR RECEPTOR SUBFAMILY 2 GROUP C MEMBER 2 (Homo sapiens)	4 / 7	LEU A 494 GLU A 444 LEU A 445 MET A 457	None	1.22A	23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	3qci	RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE GAMMA (Homo sapiens)	4 / 7	LEU A1089 ASN A1087 LEU A1116 MET A1076	None	1.25A	20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	4bgq	CYCLIN-DEPENDENT KINASE-LIKE 5 (Homo sapiens)	4 / 7	LEU A 204 LEU A 273 TYR A 177 MET A 274	None	1.20A	22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	4c9y	SPINDLE AND KINETOCHORE-ASSOCIAT ED PROTEIN 1 (Homo sapiens)	4 / 7	LEU A 101 ASN A 102 MET A   6 MET A  21	None	1.13A	20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	4hou	INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1 (Homo sapiens)	4 / 7	ASN A  68 LEU A  75 MET A  32 MET A 104	None	1.17A	23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	4n9j	SERINE/THREONINE-PRO TEIN KINASE PLK4 (Homo sapiens)	4 / 7	LEU A 637 GLU A 618 LEU A 614 TYR A 650	None	1.15A	21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	4nqj	E3 UBIQUITIN-PROTEIN LIGASE TRIM69 (Homo sapiens)	4 / 7	LEU A 240 ASN A 239 GLU A 235 LEU A 232	None	0.90A	23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	5gri	ISOCITRATE DEHYDROGENASE [NAD] SUBUNIT ALPHA, MITOCHONDRIAL (Homo sapiens)	4 / 7	LEU A 227 ASN A 226 GLU A 123 LEU A 143	None	1.23A	20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	5h64	SERINE/THREONINE-PRO TEIN KINASE MTOR (Homo sapiens)	4 / 7	LEU A1642 LEU A1596 MET A1529 MET A1595	None	1.18A	7.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	5uj8	ORIGIN RECOGNITION COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 7	LEU A  69 ASN A  68 GLU A  64 LEU A  61	None	1.15A	17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	5v88	LYSOZYME,DCN1-LIKE PROTEIN 1 (Escherichia virus T4; Homo sapiens)	4 / 7	LEU A1093 LEU A1103 MET A1126 TYR A1072	None	1.13A	21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	5w2h	INOSITOL POLYPHOSPHATE MULTIKINASE,INOSITOL POLYPHOSPHATE MULTIKINASE (Homo sapiens)	4 / 7	LEU A 296 GLU A 173 LEU A 170 MET A 143	None	1.14A	23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	6b5q	DCN1-LIKE PROTEIN 1 (Homo sapiens)	4 / 7	LEU A  93 LEU A 103 MET A 126 TYR A  72	None	1.07A	16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W8Y_A_486A1000_2 (PROGESTERONE RECEPTOR)	6ffh	METABOTROPIC GLUTAMATE RECEPTOR 5,ENDOLYSIN (Escherichia virus T4; Homo sapiens)	4 / 7	LEU A1133 ASN A1132 GLU A1128 MET A1102	None	1.23A	12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	1y8q	UBIQUITIN-LIKE 2 ACTIVATING ENZYME E1B (Homo sapiens)	5 / 12	LEU B  38 GLY B  40 VAL B  15 LEU B  32 ILE B  44	None	1.43A	16.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752 LEU A 873	BHM  A   1 (-3.6A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A)	0.69A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787 LEU A 873	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A) BHM  A   1 (-4.4A)	1.12A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A)	0.68A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A)	1.00A	48.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	2z7x	TOLL-LIKE RECEPTOR 2, VARIABLE LYMPHOCYTE RECEPTOR B (Eptatretus burgeri; Homo sapiens)	5 / 12	MET A 428 LEU A 402 GLY A 406 MET A 438 LEU A 459	None	1.21A	19.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	ASN A 719 GLY A 722 GLN A 725 MET A 756 ARG A 766 LEU A 887	WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) WOW  A   1 (-4.0A)	0.84A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 718 ASN A 719 GLY A 722 MET A 756 ARG A 766 MET A 801 LEU A 887	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-4.0A)	0.69A	53.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	4l9m	RAS GUANYL-RELEASING PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 301 GLY A 299 VAL A 452 LEU A 285 ILE A 254	None	1.41A	17.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 563 ASN A 564 GLY A 567 GLN A 570 VAL A 571 MET A 601 ARG A 611 MET A 646 LEU A 732	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.61A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	MET A 560 ASN A 564 VAL A 571 MET A 601 ARG A 611 MET A 646 LEU A 732	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) None MOF  A 801 (-3.7A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.87A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 769 ASN A 770 GLN A 776 ARG A 817 MET A 852 LEU A 938	CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) CV7  A1987 (-3.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A)	0.82A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 769 GLN A 776 MET A 807 ARG A 817 MET A 852 LEU A 938	CV7  A1987 (-4.1A) CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A)	0.74A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 MET A 807 ARG A 817 MET A 852 LEU A 938	ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) ECV  A1101 ( 4.3A)	1.35A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 ARG A 817 LEU A 938	ECV  A1101 (-4.7A) ECV  A1101 (-3.1A) ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.0A) ECV  A1101 ( 4.3A)	0.73A	53.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	5xjy	ATP-BINDING CASSETTE SUB-FAMILY A MEMBER 1 (Homo sapiens)	5 / 12	LEU A1614 ASN A1611 GLN A 602 VAL A 617 ARG A 606	None	1.30A	7.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	6avo	PROTEASOME SUBUNIT BETA TYPE-9 (Homo sapiens)	5 / 12	LEU A 115 GLY A 113 GLN A 122 VAL A 111 ILE A   3	None	1.21A	14.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	ASN A1351 TRP A1500 GLN A1528 LEU A1527 TYR A1526	None	1.31A	21.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 10	LEU A 718 MET A 756 MET A 759 LEU A 887 TYR A 890	WOW  A   1 (-4.2A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-4.0A) WOW  A   1 (-3.9A)	0.60A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 10	LEU A 563 TRP A 600 MET A 601 LEU A 732 TYR A 735	MOF  A 801 (-3.9A) None MOF  A 801 (-3.7A) MOF  A 801 ( 4.2A) MOF  A 801 (-4.8A)	0.66A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 10	LEU A 563 TRP A 600 MET A 601 MET A 604 LEU A 732	MOF  A 801 (-3.9A) None MOF  A 801 (-3.7A) None MOF  A 801 ( 4.2A)	0.76A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 10	TRP A 600 MET A 601 GLN A 642 LEU A 732 TYR A 735	None MOF  A 801 (-3.7A) None MOF  A 801 ( 4.2A) MOF  A 801 (-4.8A)	1.23A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 10	LEU A 772 TRP A 806 MET A 807 MET A 959 LEU A 960	CV7  A1987 ( 4.5A) None CV7  A1987 ( 3.9A) None None	1.41A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 10	LEU A 772 TRP A 806 MET A 807 MET A 959 LEU A 960	ECV  A1101 ( 3.9A) None ECV  A1101 (-3.6A) None None	1.22A	53.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	5vew	GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,ENDOLYSIN CHIMERA (Escherichia virus T4; Homo sapiens)	5 / 10	ASN A1132 TRP A1138 MET A1102 LEU A1099 LEU A1133	None	1.49A	18.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	1kcw	CERULOPLASMIN (Homo sapiens)	5 / 12	MET A 617 GLY A 614 GLN A 612 LEU A 561 MET A 668	None	1.25A	12.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	1lar	PROTEIN (LAR) (Homo sapiens)	5 / 12	GLY A1527 GLY A1530 GLN A1566 VAL A1565 ILE A1574	None	1.21A	16.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	GLY A 708 GLN A 711 ARG A 752 CYH A 784 MET A 787 ILE A 898	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) None BHM  A   1 (-3.6A) None	0.89A	48.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	2b3o	TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 6 (Homo sapiens)	5 / 12	GLY A 458 GLY A 461 GLN A 500 VAL A 499 ILE A 508	None	1.26A	18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	2b3x	IRON-RESPONSIVE ELEMENT BINDING PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 175 GLN A 179 VAL A 180 MET A 488 ILE A 616	None	1.28A	14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	2c7s	RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE KAPPA (Homo sapiens)	5 / 12	GLY A1088 GLY A1091 GLN A1127 VAL A1126 ILE A1135	ACT  A2156 (-3.6A) None ACT  A2156 (-3.4A) None None	1.06A	18.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	2mki	CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 4 (Homo sapiens)	5 / 12	GLY A  70 GLY A  71 GLN A 150 VAL A 149 ILE A  81	U  B   2 ( 3.9A) C  B   1 ( 2.7A) U  B   2 ( 2.8A) None None	1.09A	21.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 LEU A 763 ARG A 766 CYH A 798 MET A 801 CYH A 891	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 ( 4.1A) WOW  A   1 (-4.2A) WOW  A   1 (-3.5A)	0.87A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	GLY A 567 GLY A 568 GLN A 570 VAL A 571 LEU A 608 ARG A 611 MET A 639 CYH A 643 MET A 646	MOF  A 801 (-3.4A) None MOF  A 801 (-2.9A) None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A)	0.68A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	10 / 12	GLY A 567 GLY A 568 GLN A 570 VAL A 571 LEU A 608 ARG A 611 MET A 639 MET A 646 CYH A 736 ILE A 756	MOF  A 801 (-3.4A) None MOF  A 801 (-2.9A) None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 (-3.7A) None	0.72A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLY A 567 LEU A 608 ARG A 611 CYH A 643 MET A 646 ILE A 757	MOF  A 801 (-3.4A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A) None	1.32A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLY A 568 GLN A 570 VAL A 571 CYH A 736 ILE A 756	None MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) None	1.09A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	MET A 560 GLY A 568 VAL A 571 LEU A 608 ARG A 611 MET A 639 CYH A 643 MET A 646	MOF  A 801 (-3.9A) None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A)	0.87A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	MET A 560 GLY A 568 VAL A 571 LEU A 608 ARG A 611 MET A 639 MET A 646 CYH A 736 ILE A 756	MOF  A 801 (-3.9A) None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 (-3.7A) None	0.93A	94.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4pvg	TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11 (Homo sapiens)	5 / 12	GLY A 464 GLY A 467 GLN A 506 VAL A 505 ILE A 514	2WT  A 601 ( 3.9A) None 2WT  A 601 (-3.4A) None None	1.14A	17.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 LEU A 814 ARG A 817 CYH A 849 MET A 852	CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.2A) CV7  A1987 ( 3.7A)	0.79A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	GLY A 774 GLN A 776 LEU A 814 ARG A 817 MET A 852 CYH A 942 ILE A 963	None CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 (-4.0A) None	0.89A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 814 ARG A 817 CYH A 849 MET A 852 ILE A 964	CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.2A) CV7  A1987 ( 3.7A) None	0.94A	55.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5i6v	TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11 (Homo sapiens)	5 / 12	GLY A 464 GLY A 467 GLN A 506 VAL A 505 ILE A 514	None	1.23A	17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5lcw	CELL DIVISION CYCLE PROTEIN 20 HOMOLOG (Homo sapiens)	5 / 12	GLY Q 376 GLY Q 375 GLN Q 401 VAL Q 402 ILE Q 382	None	1.28A	20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5lcw	CELL DIVISION CYCLE PROTEIN 20 HOMOLOG (Homo sapiens)	5 / 12	GLY R 376 GLY R 375 GLN R 401 VAL R 402 ILE R 382	None	1.28A	18.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 LEU A 814 ARG A 817 CYH A 849 ILE A 964	ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A) None	1.07A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	GLY A 774 GLN A 776 LEU A 814 ARG A 817 CYH A 849 CYH A 942 ILE A 963	None ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A) ECV  A1101 (-4.0A) None	0.92A	53.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5o32	COMPLEMENT FACTOR I (Homo sapiens)	5 / 12	GLY I 343 GLY I 342 GLN I 485 VAL I 341 LEU I 484	None	1.21A	17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5t0h	26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 2 (Homo sapiens)	5 / 12	GLY f 201 GLY f 200 GLN f 205 MET f 162 ILE f 189	None	1.20A	15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_2 (GLUCOCORTICOID RECEPTOR)	5wch	PROBABLE UBIQUITIN CARBOXYL-TERMINAL HYDROLASE FAF-X (Homo sapiens)	5 / 12	GLY A1867 VAL A1866 LEU A1822 MET A1824 ILE A1578	None	1.04A	14.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 PHE A 764 MET A 787	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-3.6A)	0.92A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 GLY A 708 GLN A 711 ARG A 752 PHE A 764 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-3.6A)	0.81A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 MET A 756 LEU A 763 ARG A 766 PHE A 778 MET A 801	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) None WOW  A   1 (-4.2A)	0.81A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	LEU A 718 GLY A 722 LEU A 763 ARG A 766 PHE A 778 MET A 801	WOW  A   1 (-4.2A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) None WOW  A   1 (-4.2A)	0.97A	53.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	3p0f	URIDINE PHOSPHORYLASE 2 (Homo sapiens)	5 / 12	LEU A  52 VAL A  25 LEU A 110 PHE A  56 MET A 103	None	1.33A	22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4bqm	GLUTAMINASE LIVER ISOFORM, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 422 GLY A 430 VAL A 428 LEU A 390 MET A 398	None	1.43A	19.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	GLY A 567 GLN A 570 VAL A 571 TRP A 600 MET A 601 LEU A 608 ARG A 611 PHE A 623 MET A 646	MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None None MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-4.7A) MOF  A 801 (-4.4A)	0.66A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLY A 568 GLN A 570 VAL A 571 TRP A 600 MET A 601	None MOF  A 801 (-2.9A) None None MOF  A 801 (-3.7A)	1.02A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 563 GLY A 567 GLN A 570 VAL A 571 TRP A 600 MET A 601 PHE A 623	MOF  A 801 (-3.9A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None None MOF  A 801 (-3.7A) MOF  A 801 (-4.7A)	0.99A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 627 GLN A 570 LEU A 608 PHE A 623 MET A 646	None MOF  A 801 (-2.9A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.7A) MOF  A 801 (-4.4A)	1.33A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 PHE A 829 MET A 852	CV7  A1987 (-3.0A) None CV7  A1987 ( 3.9A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 (-4.9A) CV7  A1987 ( 3.7A)	0.62A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 769 GLN A 776 TRP A 806 PHE A 829 MET A 852	CV7  A1987 (-4.1A) CV7  A1987 (-3.0A) None CV7  A1987 (-4.9A) CV7  A1987 ( 3.7A)	1.00A	55.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	5h1y	PROBABLE ATP-DEPENDENT RNA HELICASE DDX41 (Homo sapiens)	5 / 12	LEU A 193 GLY A 195 LEU A 284 MET A 186 MET A 241	None	1.33A	23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	5kem	BDBV91 VARIABLE FAB DOMAIN HEAVY CHAIN (Homo sapiens)	5 / 12	GLY B  49 GLN B  61 VAL B  37 ARG B  64 PHE B  63	None	1.13A	19.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 MET A 852	ECV  A1101 (-2.9A) None ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A)	1.22A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 PHE A 829	ECV  A1101 (-2.9A) None ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 ( 4.9A)	0.61A	53.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_1 (GLUCOCORTICOID RECEPTOR)	5toa	ESTROGEN RECEPTOR BETA (Homo sapiens)	5 / 12	LEU A 298 TRP A 335 LEU A 343 ARG A 346 PHE A 356	EST  A 601 (-4.1A) None EST  A 601 ( 4.4A) EST  A 601 (-4.1A) EST  A 601 ( 4.9A)	0.98A	29.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	1r79	DIACYLGLYCEROL KINASE, DELTA (Homo sapiens)	3 / 3	MET A  26 CYH A  59 PRO A  81	None ZN  A 201 (-2.3A) None	1.22A	18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	2cpr	EXOSOME COMPONENT 10 (Homo sapiens)	3 / 3	MET A 569 CYH A 554 PRO A 559	None	1.15A	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	3c6g	CYTOCHROME P450 2R1 (Homo sapiens)	3 / 3	MET A 458 CYH A 448 PRO A 440	HEM  A 601 ( 4.3A) HEM  A 601 (-2.1A) None	1.32A	19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	3fd5	SELENIDE, WATER DIKINASE 1 (Homo sapiens)	3 / 3	MET A 187 CYH A 180 PRO A  74	None	1.29A	20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	4boc	DNA-DIRECTED RNA POLYMERASE, MITOCHONDRIAL (Homo sapiens)	3 / 3	MET A 268 CYH A 319 PRO A 294	None	1.26A	13.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	4kq8	CYTOCHROME P450 19A1 (Homo sapiens)	3 / 3	MET A 444 CYH A 437 PRO A 429	None HEM  A 601 (-2.3A) None	1.14A	21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	4lr2	BIS(5'-ADENOSYL)-TRI PHOSPHATASE ENPP4 (Homo sapiens)	3 / 3	MET A 345 CYH A 243 PRO A 267	None	1.17A	21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	5il0	METTL3 (Homo sapiens)	3 / 3	MET A 520 CYH A 483 PRO A 514	None	0.51A	20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	5tey	N6-ADENOSINE-METHYLT RANSFERASE 70 KDA SUBUNIT (Homo sapiens)	3 / 3	MET A 520 CYH A 483 PRO A 514	None	0.62A	18.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	5vem	ECTONUCLEOTIDE PYROPHOSPHATASE/PHOS PHODIESTERASE FAMILY MEMBER 5 (Homo sapiens)	3 / 3	MET A 348 CYH A 244 PRO A 268	None	1.22A	19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_C_486C4_2 (GLUCOCORTICOID RECEPTOR)	6flk	CEP120 (Homo sapiens)	3 / 3	MET A 501 CYH A 474 PRO A 471	None	1.15A	14.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	1hci	ALPHA-ACTININ 2 (Homo sapiens)	5 / 12	GLY A 373 LEU A 294 ARG A 298 MET A 361 LEU A 341	None	1.16A	22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	1kcw	CERULOPLASMIN (Homo sapiens)	5 / 12	MET A 617 GLY A 614 GLN A 612 LEU A 561 MET A 668	None	1.38A	12.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 LEU A 873	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A)	0.67A	48.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 ( 4.0A) BHM  A   1 (-3.8A) BHM  A   1 (-3.6A)	1.07A	48.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	2oby	PUTATIVE QUINONE OXIDOREDUCTASE (Homo sapiens)	5 / 12	GLY A  62 GLN A  95 LEU A  39 MET A 317 LEU A  44	None None None NAP  A1400 (-3.6A) None	1.48A	22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	2yd0	ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (Homo sapiens)	5 / 12	MET A 382 GLY A 377 LEU A 478 MET A 482 LEU A 448	None	1.35A	13.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 GLN A 725 MET A 756 ARG A 766 CYH A 891	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) WOW  A   1 (-3.5A)	1.13A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 GLN A 725 MET A 756 ARG A 766 LEU A 887	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) WOW  A   1 (-4.0A)	0.98A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 MET A 756 ARG A 766 MET A 801 CYH A 891	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-3.5A)	1.09A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 MET A 756 LEU A 763 ARG A 766 MET A 801 LEU A 887	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-4.0A)	0.79A	53.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4jgh	CULLIN-5 (Homo sapiens)	5 / 12	MET D 310 GLY D 283 MET D 300 MET D 231 LEU D 295	None	1.24A	22.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	GLY A 567 GLN A 570 VAL A 571 MET A 601 LEU A 608 ARG A 611 MET A 639 MET A 646 LEU A 732	MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.63A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	GLY A 567 GLN A 570 VAL A 571 MET A 601 LEU A 608 ARG A 611 MET A 646 LEU A 732 CYH A 736	MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	0.67A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLY A 568 GLN A 570 VAL A 571 MET A 601 CYH A 736	None MOF  A 801 (-2.9A) None MOF  A 801 (-3.7A) MOF  A 801 (-3.7A)	1.27A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	MET A 560 VAL A 571 MET A 601 LEU A 608 ARG A 611 MET A 639 MET A 646 LEU A 732	MOF  A 801 (-3.9A) None MOF  A 801 (-3.7A) MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.86A	94.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 MET A 807 LEU A 814 ARG A 817 LEU A 938 CYH A 942	CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.9A) CV7  A1987 (-4.0A)	0.81A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852 LEU A 938	CV7  A1987 (-3.0A) CV7  A1987 ( 3.9A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A)	0.68A	55.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 MET A 807 LEU A 814 ARG A 817 LEU A 938 CYH A 942	ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 ( 4.3A) ECV  A1101 (-4.0A)	0.79A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852 LEU A 938	ECV  A1101 (-2.9A) ECV  A1101 (-3.6A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) ECV  A1101 ( 4.3A)	1.33A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 814 ARG A 817 MET A 845 MET A 852 LEU A 934	ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) None	1.32A	53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H52_D_486D2_2 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	4 / 5	LEU A 718 ASN A 719 MET A 759 TYR A 890	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 (-3.7A) WOW  A   1 (-3.9A)	0.86A	53.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2p54	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR ALPHA (Homo sapiens)	5 / 12	CYH A 276 LEU A 321 ILE A 339 LYS A 358 HIS A 440	735  A 469 (-2.9A) 735  A 469 ( 4.3A) 735  A 469 ( 4.1A) None 735  A 469 (-4.0A)	1.45A	61.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2xxz	LYSINE-SPECIFIC DEMETHYLASE 6B (Homo sapiens)	5 / 12	CYH A1202 LEU A1458 ILE A1185 PHE A1350 MET A1351	None None EDO  A2496 (-3.5A) None None	1.50A	21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2z7x	TOLL-LIKE RECEPTOR 2, VARIABLE LYMPHOCYTE RECEPTOR B (Eptatretus burgeri; Homo sapiens)	5 / 12	SER A 108 TYR A 136 LEU A 112 ILE A  67 PHE A 120	None	1.39A	21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2z80	TOLL-LIKE RECEPTOR 2, VARIABLE LYMPHOCYTE RECEPTOR B (Eptatretus burgeri; Homo sapiens)	5 / 12	SER A 108 TYR A 136 LEU A 112 ILE A  67 PHE A 120	None	1.48A	23.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3b0q	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	10 / 12	ARG A 288 ALA A 292 TYR A 327 LEU A 330 ILE A 341 MET A 348 PHE A 363 MET A 364 LYS A 367 HIS A 449	None None None MC5  A   1 (-4.4A) MC5  A   1 (-4.5A) MC5  A   1 ( 4.0A) None MC5  A   1 (-3.7A) None MC5  A   1 (-3.9A)	0.72A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3b0q	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	10 / 12	CYH A 285 ARG A 288 ALA A 292 TYR A 327 LEU A 330 ILE A 341 MET A 348 PHE A 363 LYS A 367 HIS A 449	MC5  A   1 (-3.6A) None None None MC5  A   1 (-4.4A) MC5  A   1 (-4.5A) MC5  A   1 ( 4.0A) None None MC5  A   1 (-3.9A)	0.61A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3b0q	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	10 / 12	CYH A 285 ARG A 288 SER A 289 ALA A 292 LEU A 330 ILE A 341 MET A 348 PHE A 363 LYS A 367 HIS A 449	MC5  A   1 (-3.6A) None MC5  A   1 (-2.6A) None MC5  A   1 (-4.4A) MC5  A   1 (-4.5A) MC5  A   1 ( 4.0A) None None MC5  A   1 (-3.9A)	0.77A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3b2d	CD180 ANTIGEN (Homo sapiens)	5 / 12	SER A 528 ALA A 551 TYR A 547 LEU A 548 ILE A 511	None	1.36A	19.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3dzu	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	6 / 12	ALA D 292 LEU D 330 ILE D 341 MET D 348 MET D 364 HIS D 449	PLB  D 701 ( 4.1A) PLB  D 701 ( 4.1A) PLB  D 701 (-3.6A) PLB  D 701 ( 4.7A) PLB  D 701 ( 4.8A) None	1.10A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3dzu	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	6 / 12	ALA D 292 TYR D 327 LEU D 330 ILE D 341 MET D 364 HIS D 449	PLB  D 701 ( 4.1A) None PLB  D 701 ( 4.1A) PLB  D 701 (-3.6A) PLB  D 701 ( 4.8A) None	1.16A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3dzu	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	6 / 12	CYH D 285 ALA D 292 TYR D 327 LEU D 330 ILE D 341 HIS D 449	PLB  D 701 (-3.2A) PLB  D 701 ( 4.1A) None PLB  D 701 ( 4.1A) PLB  D 701 (-3.6A) None	1.12A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3dzu	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	5 / 12	SER D 289 ALA D 292 ILE D 341 MET D 348 HIS D 449	PLB  D 701 ( 3.9A) PLB  D 701 ( 4.1A) PLB  D 701 (-3.6A) PLB  D 701 ( 4.7A) None	0.87A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3dzu	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA (Homo sapiens)	5 / 12	SER D 289 ALA D 292 TYR D 327 ILE D 341 HIS D 449	PLB  D 701 ( 3.9A) PLB  D 701 ( 4.1A) None PLB  D 701 (-3.6A) None	0.97A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4f9o	HEXOKINASE-1 (Homo sapiens)	5 / 12	CYH A 823 SER A 827 ALA A 830 ILE A 757 PHE A 786	None	1.04A	16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4fmu	HISTONE-LYSINE N-METHYLTRANSFERASE SETD2 (Homo sapiens)	5 / 12	CYH A1580 ARG A1625 SER A1624 LEU A1475 HIS A1549	None 0UM  A1804 (-4.9A) None None None	1.48A	21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5c1b	TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (Homo sapiens)	5 / 12	ALA A 622 LEU A 639 ILE A 601 PHE A 563 MET A 608	None None CL  A 905 (-4.6A) None None	1.46A	16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2c3n	GLUTATHIONE S-TRANSFERASE THETA 1 (Homo sapiens)	4 / 4	LYS A 216 GLN A 208 ILE A  19 LEU A   7	None	1.17A	23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2pg6	CYTOCHROME P450 2A6 (Homo sapiens)	4 / 4	LYS A 250 GLN A 242 ILE A 208 LEU A 202	None	0.96A	18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2xa7	AP-2 COMPLEX SUBUNIT BETA (Homo sapiens)	4 / 4	LYS B 318 GLN B 311 ILE B 564 LEU B 267	None	1.30A	20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3vi3	INTEGRIN ALPHA-5 (Homo sapiens)	4 / 4	LYS A 559 GLN A 599 ILE A 565 LEU A 520	None	1.21A	18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4hsu	LYSINE-SPECIFIC HISTONE DEMETHYLASE 1B (Homo sapiens)	4 / 4	LYS A 690 GLN A 534 ILE A 468 LEU A 737	None	1.30A	18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	5u03	CTP SYNTHASE 1 (Homo sapiens)	4 / 4	LYS A 284 GLN A 277 ILE A 274 LEU A  27	None	1.41A	19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QT0_A_486A4_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	6b3e	CYCLIN-DEPENDENT KINASE 12 (Homo sapiens)	4 / 4	LYS A 861 GLN A 937 ILE A 948 LEU A 906	None	1.21A	14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	1jmo	HEPARIN COFACTOR II (Homo sapiens)	5 / 12	LEU A 386 LEU A 457 MET A 471 ILE A 134 ILE A 139	None	1.09A	19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	1qgr	PROTEIN (IMPORTIN BETA SUBUNIT) (Homo sapiens)	5 / 12	LEU A 166 ILE A 157 GLU A 172 ILE A 173 ALA A 176	None	0.93A	14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	1s35	SPECTRIN BETA CHAIN, ERYTHROCYTE (Homo sapiens)	5 / 12	LEU A1153 VAL A1084 LEU A1100 ILE A1106 ILE A1110	None SO4  A 301 ( 4.6A) None None None	0.87A	23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	1xb7	STEROID HORMONE RECEPTOR ERR1 (Homo sapiens)	6 / 12	LEU A 509 LEU A 350 GLN A 353 MET A 354 GLN A 358 ALA A 516	None	1.43A	25.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 712 VAL A 716 GLN A 733 ILE A 737 MET A 894 GLU A 897	None	0.87A	60.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 712 VAL A 716 GLN A 733 MET A 894 GLU A 897 ILE A 898	None	1.11A	60.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 712 VAL A 716 LYS A 720 ILE A 737 MET A 894 GLU A 897	None	1.18A	60.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 712 VAL A 716 LYS A 720 MET A 894 GLU A 897 ILE A 898	None	1.27A	60.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2b3o	TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 6 (Homo sapiens)	5 / 12	VAL A 465 LEU A 251 ILE A 508 ILE A 512 ALA A 221	None	1.03A	19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	2gpv	ESTROGEN-RELATED RECEPTOR GAMMA (Homo sapiens)	5 / 12	LEU A 276 LEU A 294 GLN A 297 MET A 298 GLN A 302	OHT  A 500 (-4.9A) None None None None	0.70A	27.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	3fd5	SELENIDE, WATER DIKINASE 1 (Homo sapiens)	5 / 12	LEU A 203 LEU A 328 ILE A 354 ILE A 271 ALA A 275	None	0.92A	21.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	LEU A 726 VAL A 730 GLN A 747 ILE A 751 MET A 908 ALA A 915	None	0.69A	66.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	VAL A 730 GLN A 747 ILE A 751 GLN A 752 ALA A 915	None	0.90A	66.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	3tx7	NUCLEAR RECEPTOR SUBFAMILY 5 GROUP A MEMBER 2 (Homo sapiens)	6 / 12	LEU B 353 VAL B 357 GLN B 374 GLN B 379 GLU B 534 ALA B 538	None	0.52A	24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4cvh	ISOPRENOID SYNTHASE DOMAIN-CONTAINING PROTEIN (Homo sapiens)	6 / 12	LEU A 134 VAL A  50 LEU A 167 ILE A 154 ILE A 222 ALA A 179	None	1.25A	21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4d86	POLY [ADP-RIBOSE] POLYMERASE 14 (Homo sapiens)	5 / 12	LEU A 804 VAL A 806 LEU A 930 ILE A 941 ALA A 940	None	1.08A	19.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	VAL A 575 LEU A 589 GLN A 592 MET A 593 GLN A 597 GLU A 755 ILE A 756	None	0.75A	62.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4qkf	ALPHA-KETOGLUTARATE- DEPENDENT DIOXYGENASE ALKB HOMOLOG 7, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 110 LEU A 145 ILE A 179 ILE A  70 ALA A  69	OGA  A 301 ( 4.6A) None None None None	1.09A	23.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	VAL A 781 GLN A 798 ILE A 802 GLN A 803 GLU A 962 ILE A 963	None	0.50A	65.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	VAL A 781 LEU A 795 GLN A 798 ILE A 802 GLN A 803	None	0.73A	65.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4wxx	DNA (CYTOSINE-5)-METHYLT RANSFERASE 1 (Homo sapiens)	5 / 12	LEU A1265 MET A1169 GLU A1168 ILE A1167 ALA A1166	None SAH  A1706 (-3.9A) SAH  A1706 (-2.8A) None None	1.08A	11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	4y85	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8 (Homo sapiens)	6 / 12	VAL A 249 LEU A 273 ILE A 181 GLN A 182 ILE A 190 ALA A 191	None None None None None 499  A 401 ( 4.6A)	1.35A	21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5aek	SENTRIN-SPECIFIC PROTEASE 2 (Homo sapiens)	6 / 12	LEU A 368 LEU A 422 MET A 372 GLU A 375 ILE A 376 ALA A 379	None	1.04A	22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5c1b	TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE (Homo sapiens)	5 / 12	LEU A 579 GLN A 603 ILE A 604 ILE A 633 ALA A 632	None	1.02A	15.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5dkc	PROBABLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L2 (Homo sapiens)	5 / 12	LEU A1383 GLN A1386 MET A1387 ILE A1390 MET A1454	None	1.03A	21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5exr	DNA POLYMERASE ALPHA CATALYTIC SUBUNIT (Homo sapiens)	5 / 12	LEU C 708 VAL C 712 ILE C 755 ILE C 752 ALA C 541	None	0.98A	12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5iud	DNA POLYMERASE ALPHA CATALYTIC SUBUNIT (Homo sapiens)	5 / 12	LEU A 708 VAL A 712 ILE A 755 ILE A 752 ALA A 541	None	1.01A	13.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A302_1 (ANCESTRAL STEROID RECEPTOR 2)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	VAL A 781 LEU A 795 GLN A 798 ILE A 802 GLN A 803 ILE A 963	None	0.79A	47.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	2bzn	GMP REDUCTASE 2 (Homo sapiens)	5 / 9	THR A  74 LEU A  99 ALA A  64 GLN A  91 PHE A  88	None	1.27A	21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	2d68	FOP (Homo sapiens)	5 / 9	ALA A  75 LEU A  82 PHE A  94 THR A  98 LEU A  62	None	1.36A	15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	2dam	ETEA PROTEIN (Homo sapiens)	5 / 9	ALA A  51 GLN A  24 PHE A  25 THR A  29 LEU A  56	None	1.43A	16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	2jr7	DPH3 HOMOLOG (Homo sapiens)	5 / 9	ALA A  46 GLN A  14 PHE A  13 TYR A  22 LEU A  39	None	1.32A	16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	3b2d	CD180 ANTIGEN (Homo sapiens)	5 / 9	THR A 308 LEU A 305 GLN A 295 PHE A 294 LEU A 281	None	1.28A	19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	3cjw	COUP TRANSCRIPTION FACTOR 2 (Homo sapiens)	5 / 9	LEU A 245 ALA A 227 LEU A 236 THR A 248 LEU A 252	None	1.38A	26.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	4gul	PIRIN (Homo sapiens)	5 / 9	LEU A 116 LEU A  36 PHE A 193 TYR A 195 LEU A 114	None	1.41A	20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	4lhu	9C2 TCR GAMMA CHAIN (Homo sapiens)	5 / 9	THR G  73 LEU G  83 LEU G  66 GLN G  48 TYR G  39	None	1.44A	18.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 9	LEU A 766 LEU A 848 PHE A 941 TYR A 944 THR A 945 LEU A 952	CV7  A1987 (-3.6A) CV7  A1987 ( 4.4A) CV7  A1987 (-4.6A) None CV7  A1987 (-3.1A) None	0.51A	65.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	5liy	ALDO-KETO REDUCTASE FAMILY 1 MEMBER B10 (Homo sapiens)	5 / 9	THR X   9 LEU X   7 ALA X 156 GLN X 184 THR X 206	None None MLZ  X 155 ( 3.0A) NAP  X 401 (-3.8A) EDO  X 403 (-4.6A)	1.27A	21.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4LTW_A_486A303_1 (ANCESTRAL STEROID RECEPTOR 2)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 9	LEU A 766 ALA A 844 LEU A 848 PHE A 941 TYR A 944 THR A 945 LEU A 952	ECV  A1101 ( 3.9A) None None ECV  A1101 (-4.3A) None ECV  A1101 (-3.2A) None	0.47A	47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 GLY A 708 GLN A 711 MET A 745 ARG A 752 CYH A 784 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) None BHM  A   1 (-3.6A)	0.95A	50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 LEU A 707 GLY A 708 GLN A 711 ARG A 752 CYH A 784 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 4.2A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) None BHM  A   1 (-3.6A)	0.73A	50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 346 LEU A 349 TRP A 383 LEU A 391 ARG A 394	EST  A 596 (-4.4A) EST  A 596 ( 4.1A) None EST  A 596 ( 4.6A) EST  A 596 (-4.0A)	0.78A	15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3dwb	ENDOTHELIN-CONVERTIN G ENZYME 1 (Homo sapiens)	5 / 12	LEU A 705 LEU A 708 GLY A 709 GLN A 712 VAL A 713	None	0.38A	8.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 718 GLY A 722 MET A 759 LEU A 763 ARG A 766 CYH A 798 MET A 801	WOW  A   1 (-4.2A) WOW  A   1 ( 4.3A) WOW  A   1 (-3.7A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 ( 4.1A) WOW  A   1 (-4.2A)	0.89A	56.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 718 LEU A 721 GLY A 722 LEU A 763 ARG A 766 CYH A 798 MET A 801	WOW  A   1 (-4.2A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 ( 4.1A) WOW  A   1 (-4.2A)	0.67A	56.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3t5o	COMPLEMENT COMPONENT C6 (Homo sapiens)	5 / 12	LEU A 302 LEU A 350 GLY A 351 GLY A 352 VAL A 455	None	1.11A	7.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4l52	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 CHIMERA (Homo sapiens)	5 / 12	LEU A 298 GLY A 168 GLY A 167 LEU A 112 CYH A 134	None	1.12A	16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4nz6	TRNA PSEUDOURIDINE SYNTHASE A, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 205 GLY A 332 GLY A 330 VAL A 149 CYH A 268	None None None DLY  A 403 (-4.4A) None	1.15A	14.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	LEU A 563 LEU A 566 GLY A 567 GLY A 568 GLN A 570 VAL A 571 MET A 604 LEU A 608 ARG A 611 CYH A 643 MET A 646	MOF  A 801 (-3.9A) MOF  A 801 ( 4.6A) MOF  A 801 (-3.4A) None MOF  A 801 (-2.9A) None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A)	0.83A	96.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	LEU A 566 GLY A 567 GLY A 568 GLN A 570 VAL A 571 TRP A 600 MET A 604 LEU A 608 ARG A 611 CYH A 643 MET A 646	MOF  A 801 ( 4.6A) MOF  A 801 (-3.4A) None MOF  A 801 (-2.9A) None None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A)	0.93A	96.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 769 LEU A 772 GLN A 776 LEU A 814 ARG A 817 CYH A 849 MET A 852	CV7  A1987 (-4.1A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.2A) CV7  A1987 ( 3.7A)	0.72A	47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 769 LEU A 772 GLY A 774 GLN A 776 LEU A 814 ARG A 817 MET A 852	CV7  A1987 (-4.1A) CV7  A1987 ( 4.5A) None CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A)	0.71A	47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 772 GLN A 776 TRP A 806 LEU A 814 ARG A 817 CYH A 849 MET A 852	CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) None CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.2A) CV7  A1987 ( 3.7A)	0.68A	47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 772 GLY A 774 GLN A 776 TRP A 806 LEU A 814 ARG A 817 MET A 852	CV7  A1987 ( 4.5A) None CV7  A1987 (-3.0A) None CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A)	0.87A	47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 769 LEU A 772 GLY A 774 GLN A 776 LEU A 814 ARG A 817 CYH A 849	ECV  A1101 (-4.7A) ECV  A1101 ( 3.9A) None ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A)	0.81A	43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 772 GLN A 776 LEU A 814 ARG A 817 CYH A 849 MET A 852	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A) ECV  A1101 (-3.7A)	1.00A	43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 772 GLN A 776 TRP A 806 LEU A 814 ARG A 817 MET A 852	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) None ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.7A)	1.22A	43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 772 GLY A 774 GLN A 776 TRP A 806 LEU A 814 ARG A 817	ECV  A1101 ( 3.9A) None ECV  A1101 (-2.9A) None ECV  A1101 (-4.1A) ECV  A1101 (-4.0A)	0.80A	43.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 412 LEU A 409 GLY A 603 GLY A 602 LEU A 424	None	0.97A	21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	1hcf	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	3 / 3	TRP X 301 MET X 379 ASN X 356	None	1.19A	17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	1uwy	CARBOXYPEPTIDASE M (Homo sapiens)	3 / 3	TRP A 241 MET A 229 ASN A 230	None	1.41A	10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2c6a	UBIQUITIN-PROTEIN LIGASE E3 MDM2 (Homo sapiens)	3 / 3	TRP A 303 MET A 311 ASN A 309	None	1.34A	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2ifg	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	TRP A 299 MET A 379 ASN A 356	None	1.06A	12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3ctt	MALTASE-GLUCOAMYLASE (Homo sapiens)	3 / 3	TRP A 423 MET A 388 ASN A 419	None	1.31A	6.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3f1s	VITAMIN K-DEPENDENT PROTEIN Z (Homo sapiens)	3 / 3	TRP B 354 MET B 211 ASN B 220	None	1.37A	17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3h5c	VITAMIN K-DEPENDENT PROTEIN Z (Homo sapiens)	3 / 3	TRP B 354 MET B 211 ASN B 220	None	1.33A	14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5y3r	DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (Homo sapiens)	3 / 3	TRP C2245 MET C2220 ASN C2217	None	1.45A	1.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	1hcf	BDNF/NT-3 GROWTH FACTORS RECEPTOR (Homo sapiens)	3 / 3	TRP X 301 MET X 379 ASN X 356	None	1.16A	17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	1kcw	CERULOPLASMIN (Homo sapiens)	3 / 3	TRP A 364 MET A 608 ASN A 611	None	1.02A	6.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	1uwy	CARBOXYPEPTIDASE M (Homo sapiens)	3 / 3	TRP A 241 MET A 229 ASN A 230	None	1.46A	10.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2c6a	UBIQUITIN-PROTEIN LIGASE E3 MDM2 (Homo sapiens)	3 / 3	TRP A 303 MET A 311 ASN A 309	None	1.27A	15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ifg	HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR (Homo sapiens)	3 / 3	TRP A 299 MET A 379 ASN A 356	None	1.02A	12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3ctt	MALTASE-GLUCOAMYLASE (Homo sapiens)	3 / 3	TRP A 423 MET A 388 ASN A 419	None	1.37A	6.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3f1s	VITAMIN K-DEPENDENT PROTEIN Z (Homo sapiens)	3 / 3	TRP B 354 MET B 211 ASN B 220	None	1.39A	17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3h5c	VITAMIN K-DEPENDENT PROTEIN Z (Homo sapiens)	3 / 3	TRP B 354 MET B 211 ASN B 220	None	1.34A	14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4f02	POLYADENYLATE-BINDIN G PROTEIN 1 (Homo sapiens)	3 / 3	TRP A  86 MET A  85 ASN A  73	None A  B   6 (-3.3A) None	1.22A	16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	5y3r	DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (Homo sapiens)	3 / 3	TRP C2245 MET C2220 ASN C2217	None	1.45A	1.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 745 ARG A 752	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A)	0.86A	50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 LEU A 707 GLY A 708 GLN A 711 ARG A 752	BHM  A   1 (-4.0A) BHM  A   1 (-3.6A) BHM  A   1 ( 4.2A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A)	0.64A	50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 GLY A 708 GLN A 711 MET A 745 ARG A 752 CYH A 784 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) None BHM  A   1 (-3.6A)	0.96A	50.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 LEU A 707 GLY A 708 GLN A 711 ARG A 752 CYH A 784 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 4.2A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) None BHM  A   1 (-3.6A)	0.75A	50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	3dwb	ENDOTHELIN-CONVERTIN G ENZYME 1 (Homo sapiens)	5 / 12	LEU A 705 LEU A 708 GLY A 709 GLN A 712 VAL A 713	None	0.36A	8.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	ASN A 719 LEU A 721 GLY A 722 GLN A 725 ARG A 766	WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A)	0.84A	56.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	LEU A 718 ASN A 719 LEU A 721 GLY A 722 LEU A 763 ARG A 766 CYH A 798 MET A 801	WOW  A   1 (-4.2A) WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 ( 4.1A) WOW  A   1 (-4.2A)	0.77A	56.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 718 GLY A 722 MET A 759 LEU A 763 ARG A 766 CYH A 798 MET A 801	WOW  A   1 (-4.2A) WOW  A   1 ( 4.3A) WOW  A   1 (-3.7A) WOW  A   1 ( 4.0A) WOW  A   1 (-3.8A) WOW  A   1 ( 4.1A) WOW  A   1 (-4.2A)	0.90A	56.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	3t5o	COMPLEMENT COMPONENT C6 (Homo sapiens)	5 / 12	LEU A 302 LEU A 350 GLY A 351 GLY A 352 VAL A 455	None	1.16A	7.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4b94	DUAL SPECIFICITY PROTEIN KINASE TTK (Homo sapiens)	5 / 12	LEU A  84 ASN A  85 LEU A  87 GLY A  89 ARG A 115	None	0.99A	19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4h7y	DUAL SPECIFICITY PROTEIN KINASE TTK (Homo sapiens)	5 / 12	LEU A  35 ASN A  36 LEU A  38 GLY A  40 ARG A  66	None	0.82A	18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4l52	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7, TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 CHIMERA (Homo sapiens)	5 / 12	LEU A 298 GLY A 168 GLY A 167 LEU A 112 CYH A 134	None	1.09A	16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4nz6	TRNA PSEUDOURIDINE SYNTHASE A, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 205 GLY A 332 GLY A 330 VAL A 149 CYH A 268	None None None DLY  A 403 (-4.4A) None	1.13A	14.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	12 / 12	LEU A 563 ASN A 564 LEU A 566 GLY A 567 GLY A 568 GLN A 570 VAL A 571 MET A 604 LEU A 608 ARG A 611 CYH A 643 MET A 646	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) MOF  A 801 ( 4.6A) MOF  A 801 (-3.4A) None MOF  A 801 (-2.9A) None None MOF  A 801 ( 4.6A) MOF  A 801 (-4.2A) MOF  A 801 ( 3.7A) MOF  A 801 (-4.4A)	0.87A	96.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 LEU A 772 GLY A 774 GLN A 776 LEU A 814 ARG A 817 MET A 852	CV7  A1987 (-4.1A) CV7  A1987 (-3.1A) CV7  A1987 ( 4.5A) None CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 3.7A)	0.77A	47.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 769 LEU A 772 GLN A 776 LEU A 814 ARG A 817 CYH A 849 MET A 852	CV7  A1987 (-4.1A) CV7  A1987 ( 4.5A) CV7  A1987 (-3.0A) CV7  A1987 ( 4.0A) CV7  A1987 (-3.7A) CV7  A1987 ( 4.2A) CV7  A1987 ( 3.7A)	0.73A	47.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	5iy7	GENERAL TRANSCRIPTION FACTOR IIE SUBUNIT 1 (Homo sapiens)	5 / 12	LEU Q  63 ASN Q  64 LEU Q  66 GLY Q  68 LEU Q  37	None	1.12A	9.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 LEU A 772 GLY A 774 GLN A 776 LEU A 814 ARG A 817 CYH A 849	ECV  A1101 (-4.7A) ECV  A1101 (-3.1A) ECV  A1101 ( 3.9A) None ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A)	0.84A	43.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	LEU A 772 GLN A 776 LEU A 814 ARG A 817 CYH A 849 MET A 852	ECV  A1101 ( 3.9A) ECV  A1101 (-2.9A) ECV  A1101 (-4.1A) ECV  A1101 (-4.0A) ECV  A1101 (-3.8A) ECV  A1101 (-3.7A)	0.98A	43.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 412 LEU A 409 GLY A 603 GLY A 602 LEU A 424	None	0.96A	21.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	ASN A 705 GLY A 708 GLN A 711 MET A 745 ARG A 752 PHE A 764 LEU A 873	BHM  A   1 (-3.6A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-4.4A)	0.75A	51.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	GLY A 708 GLN A 711 MET A 745 ARG A 752 PHE A 764 MET A 787	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.9A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-3.6A)	0.72A	51.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	MET A 343 ARG A 394 PHE A 404 MET A 421 LEU A 384	EST  A 596 (-4.8A) EST  A 596 (-4.0A) None EST  A 596 (-4.5A) None	1.26A	15.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	ASN A 719 GLY A 722 GLN A 725 MET A 759 ARG A 766 MET A 801 LEU A 887	WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) WOW  A   1 (-4.2A) WOW  A   1 (-4.0A)	0.85A	53.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	ASN A 719 GLY A 722 MET A 759 ARG A 766 PHE A 778 MET A 801 LEU A 887 CYH A 891	WOW  A   1 (-3.3A) WOW  A   1 ( 4.3A) WOW  A   1 (-3.7A) WOW  A   1 (-3.8A) None WOW  A   1 (-4.2A) WOW  A   1 (-4.0A) WOW  A   1 (-3.5A)	0.70A	53.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	ASN A 564 GLY A 567 GLN A 570 MET A 604 ARG A 611 PHE A 623 MET A 639 MET A 646 LEU A 732	MOF  A 801 (-3.0A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-4.2A) MOF  A 801 (-4.7A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A)	0.69A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	10 / 12	ASN A 564 GLY A 567 GLN A 570 TRP A 600 ARG A 611 PHE A 623 MET A 639 MET A 646 LEU A 732 CYH A 736	MOF  A 801 (-3.0A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None MOF  A 801 (-4.2A) MOF  A 801 (-4.7A) MOF  A 801 (-3.7A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	0.70A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	MET A 560 ASN A 564 TRP A 600 MET A 646 LEU A 732 CYH A 736	MOF  A 801 (-3.9A) MOF  A 801 (-3.0A) None MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	1.00A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	ASN A 770 GLN A 776 TRP A 806 ARG A 817 PHE A 829 MET A 852 LEU A 938 CYH A 942	CV7  A1987 (-3.1A) CV7  A1987 (-3.0A) None CV7  A1987 (-3.7A) CV7  A1987 (-4.9A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A) CV7  A1987 (-4.0A)	0.72A	48.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 770 GLN A 776 TRP A 806 ARG A 817 PHE A 829 LEU A 938 CYH A 942	ECV  A1101 (-3.1A) ECV  A1101 (-2.9A) None ECV  A1101 (-4.0A) ECV  A1101 ( 4.9A) ECV  A1101 ( 4.3A) ECV  A1101 (-4.0A)	0.70A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 TRP A 806 ARG A 817 MET A 852 LEU A 938	ECV  A1101 (-2.9A) None ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) ECV  A1101 ( 4.3A)	1.27A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	1uwy	CARBOXYPEPTIDASE M (Homo sapiens)	4 / 5	LEU A 263 LEU A 265 MET A  65 GLN A 249	None	1.22A	9.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2b92	INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 1 (Homo sapiens)	4 / 5	LEU A 208 LEU A 224 MET A 139 TYR A 204	LEU  A 208 ( 0.6A) LEU  A 224 ( 0.6A) MET  A 139 ( 0.0A) TYR  A 204 ( 1.3A)	1.44A	13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2ilr	FANCONI ANEMIA GROUP E PROTEIN (Homo sapiens)	4 / 5	LEU A 402 LEU A 420 MET A 426 TYR A 394	None	1.42A	14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2nsm	CARBOXYPEPTIDASE N CATALYTIC CHAIN (Homo sapiens)	4 / 5	LEU A 287 LEU A 289 MET A  65 GLN A 273	None	1.24A	11.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	2pxx	UNCHARACTERIZED PROTEIN MGC2408 (Homo sapiens)	4 / 5	LEU A  72 LEU A  76 MET A  97 TYR A  39	None None UNX  A 300 (-3.5A) None	1.35A	18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 5	LEU A1027 LEU A1026 MET A1034 TYR A1050	None	1.42A	6.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3ojy	COMPLEMENT COMPONENT C8 ALPHA CHAIN (Homo sapiens)	4 / 5	LEU A 446 LEU A 438 MET A 279 GLN A  65	None	1.34A	9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	4akv	SORTING NEXIN-33 (Homo sapiens)	4 / 5	LEU A 469 LEU A 465 MET A 545 GLN A 476	None	1.40A	12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	4bsn	EXPORTIN-1 (Homo sapiens)	4 / 5	LEU A 233 LEU A 230 MET A 213 TYR A 240	None	1.43A	6.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	4 / 5	LEU A 563 LEU A 566 MET A 601 TYR A 735	MOF  A 801 (-3.9A) MOF  A 801 ( 4.6A) MOF  A 801 (-3.7A) MOF  A 801 (-4.8A)	1.01A	100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5a31	ANAPHASE-PROMOTING COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 5	LEU A1609 LEU A1612 MET A1373 TYR A1589	None	1.17A	4.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5iz5	CYTOSOLIC PHOSPHOLIPASE A2 DELTA (Homo sapiens)	4 / 5	LEU B  51 LEU B  88 MET B 632 GLN B 610	None	1.28A	8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5lcw	ANAPHASE-PROMOTING COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 5	LEU A1609 LEU A1612 MET A1373 TYR A1589	None	1.18A	3.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5lub	LEGUMAIN (Homo sapiens)	4 / 5	LEU B 161 LEU B 154 MET B  69 GLN B 111	None	1.20A	15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	5vk1	PROTEIN MDM4 (Homo sapiens)	4 / 5	LEU A  85 LEU A  81 MET A  53 TYR A  99	None	1.40A	22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	6axf	RAS GUANYL-RELEASING PROTEIN 2 (Homo sapiens)	4 / 5	LEU A 314 LEU A 318 MET A  42 TYR A 178	None	1.34A	11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	6co1	TUDOR-INTERACTING REPAIR REGULATOR PROTEIN (Homo sapiens)	4 / 5	LEU A 161 LEU A 192 MET A 183 TYR A 148	None	1.34A	22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	6d6u	GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT GAMMA-2,GAMMA-AMINOB UTYRIC ACID RECEPTOR SUBUNIT GAMMA-2 (Homo sapiens)	4 / 5	LEU E 246 LEU E 250 MET E 276 TYR E 241	None	1.46A	22.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 ARG A 752 PHE A 764 LEU A 873	BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-4.4A)	0.69A	51.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 GLY A 708 GLN A 711 ARG A 752 PHE A 764 MET A 787	BHM  A   1 (-4.0A) BHM  A   1 ( 3.8A) BHM  A   1 (-2.2A) BHM  A   1 (-3.8A) BHM  A   1 (-4.4A) BHM  A   1 (-3.6A)	0.70A	51.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ebz	REGULATOR OF G-PROTEIN SIGNALING 12 (Homo sapiens)	5 / 12	LEU A  23 GLY A  28 PHE A  19 MET A 117 LEU A  36	None	1.27A	20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	MET A 343 LEU A 346 ARG A 394 PHE A 404 LEU A 384	EST  A 596 (-4.8A) EST  A 596 (-4.4A) EST  A 596 (-4.0A) None None	1.11A	15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2ocf	ESTROGEN RECEPTOR (Homo sapiens)	5 / 12	MET A 343 LEU A 346 TRP A 383 ARG A 394 PHE A 404	EST  A 596 (-4.8A) EST  A 596 (-4.4A) None EST  A 596 (-4.0A) None	0.81A	15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	2wl8	PEROXISOMAL BIOGENESIS FACTOR 19 (Homo sapiens)	5 / 12	LEU A 268 GLY A 270 GLN A 221 MET A 225 LEU A 258	None	1.26A	23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3d8b	FIDGETIN-LIKE PROTEIN 1 (Homo sapiens)	5 / 12	MET A 608 LEU A 611 ARG A 649 PHE A 648 LEU A 588	None	1.43A	14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3gf9	INTERSECTIN 2 (Homo sapiens)	5 / 12	LEU A1319 GLY A1283 PHE A1226 MET A1211 LEU A1301	UNX  A   3 (-4.5A) UNX  A   3 (-3.4A) None None None	1.29A	17.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 GLN A 725 ARG A 766 PHE A 778 MET A 801 LEU A 887	WOW  A   1 ( 4.3A) WOW  A   1 ( 4.1A) WOW  A   1 (-3.8A) None WOW  A   1 (-4.2A) WOW  A   1 (-4.0A)	0.68A	53.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	LEU A 718 GLY A 722 ARG A 766 PHE A 778 MET A 801 LEU A 887 CYH A 891	WOW  A   1 (-4.2A) WOW  A   1 ( 4.3A) WOW  A   1 (-3.8A) None WOW  A   1 (-4.2A) WOW  A   1 (-4.0A) WOW  A   1 (-3.5A)	0.52A	53.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	3kbh	ANGIOTENSIN-CONVERTI NG ENZYME 2 (Homo sapiens)	5 / 12	GLY A 377 GLN A 380 PHE A 314 GLN A 526 LEU A 529	None	1.49A	9.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4nen	INTEGRIN ALPHA-X INTEGRIN BETA-2 (Homo sapiens)	5 / 12	MET B 218 LEU B 215 GLY B 213 ARG A 407 PHE B 245	None	1.49A	8.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	10 / 12	LEU A 563 GLY A 567 GLN A 570 VAL A 571 TRP A 600 ARG A 611 PHE A 623 MET A 646 LEU A 732 CYH A 736	MOF  A 801 (-3.9A) MOF  A 801 (-3.4A) MOF  A 801 (-2.9A) None None MOF  A 801 (-4.2A) MOF  A 801 (-4.7A) MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	0.63A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	MET A 560 VAL A 571 TRP A 600 MET A 646 LEU A 732 CYH A 736	MOF  A 801 (-3.9A) None None MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	0.92A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	TRP A 600 GLN A 642 MET A 646 LEU A 732 CYH A 736	None None MOF  A 801 (-4.4A) MOF  A 801 ( 4.2A) MOF  A 801 (-3.7A)	0.99A	100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 GLN A 776 TRP A 806 ARG A 817 PHE A 829 MET A 852 LEU A 938 CYH A 942	CV7  A1987 (-4.1A) CV7  A1987 (-3.0A) None CV7  A1987 (-3.7A) CV7  A1987 (-4.9A) CV7  A1987 ( 3.7A) CV7  A1987 ( 3.9A) CV7  A1987 (-4.0A)	0.58A	48.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	4wmh	HEME OXYGENASE 2 (Homo sapiens)	5 / 12	MET A 158 LEU A 161 GLY A 164 GLN A 165 VAL A 166	None	1.17A	15.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 TRP A 806 ARG A 817 MET A 852 LEU A 938	ECV  A1101 (-2.9A) None ECV  A1101 (-4.0A) ECV  A1101 (-3.7A) ECV  A1101 ( 4.3A)	1.25A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	LEU A 769 GLN A 776 TRP A 806 ARG A 817 PHE A 829 LEU A 938 CYH A 942	ECV  A1101 (-4.7A) ECV  A1101 (-2.9A) None ECV  A1101 (-4.0A) ECV  A1101 ( 4.9A) ECV  A1101 ( 4.3A) ECV  A1101 (-4.0A)	0.60A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_1 (GLUCOCORTICOID RECEPTOR)	5txf	PHOSPHATIDYLCHOLINE- STEROL ACYLTRANSFERASE (Homo sapiens)	5 / 12	LEU A 191 GLY A 308 GLN A 363 PHE A 206 LEU A 301	None	1.34A	11.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	4igg	CATENIN ALPHA-1 (Homo sapiens)	4 / 4	ASN A 791 MET A 723 MET A 726 TYR A 786	None	0.94A	7.21